Martha Blaney

Author PubWeight™ 18.25‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Effect of door-to-balloon time on mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol 2006 4.11
2 Racial and ethnic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction. JAMA 2004 3.45
3 Achieving door-to-balloon times that meet quality guidelines: how do successful hospitals do it? J Am Coll Cardiol 2005 1.79
4 Hospital improvement in time to reperfusion in patients with acute myocardial infarction, 1999 to 2002. J Am Coll Cardiol 2005 1.69
5 Early coronary revascularization diminishes the risk of ischemic stroke with acute myocardial infarction. Stroke 2006 1.44
6 Door-to-drug and door-to-balloon times: where can we improve? Time to reperfusion therapy in patients with ST-segment elevation myocardial infarction (STEMI). Am Heart J 2006 1.21
7 Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction. Circulation 2007 0.98
8 A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3. Clin J Am Soc Nephrol 2010 0.79
9 TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters. J Vasc Interv Radiol 2010 0.77
10 Tenecteplase for the improvement of blood flow rate in dysfunctional hemodialysis catheters. Clin Nephrol 2012 0.77
11 A phase III, open-label, single-arm study of tenecteplase for restoration of function in dysfunctional central venous catheters. J Vasc Interv Radiol 2011 0.76
12 Re: catheter-directed thrombolytic therapy for limb ischemia: current status and controversies. J Vasc Interv Radiol 2004 0.75
13 Improvement of hemodialysis catheter function with tenecteplase: a phase III, open-label study: TROPICS 4. J Thromb Thrombolysis 2011 0.75